Thrombin-Induced Oxidative Stress Contributes to the Death of Hippocampal NeuronsIn Vivo: Role of Microglial NADPH Oxidase
Open Access
- 20 April 2005
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 25 (16), 4082-4090
- https://doi.org/10.1523/jneurosci.4306-04.2005
Abstract
The present study investigated whether thrombin, a potent microglial activator, can induce reactive oxygen species (ROS) generation through activation of microglial NADPH oxidase and if this may contribute to oxidative damage and consequent neurodegeneration. Seven days after intrahippocampal injection of thrombin, Nissl staining and immunohistochemistry using the neuronal-specific nuclear protein NeuN revealed a significant loss in hippocampal CA1 neurons. In parallel, thrombin-activated microglia, assessed by OX-42 and OX-6 immunohistochemistry, and ROS production, assessed by hydroethidine histochemistry, were observed in the hippocampal CA1 area in which degeneration of hippocampal neurons occurred. Reverse transcription-PCR at various time points after thrombin administration demonstrated an early and transient expression of inducible nitric oxide synthase (iNOS) and several proinflammatory cytokines. Western blot analysis and double-label immunohistochemistry showed an increase in the expression of and the localization of iNOS within microglia. Additional studies demonstrated that thrombin induced the upregulation of membrane (gp91phox) and cytosolic (p47phoxand p67phox) components, translocation of cytosolic proteins (p47phox, p67phox, and Rac1) to the membrane, and p67phoxexpression of the NADPH oxidase in microglia in the hippocampusin vivo, indicating the activation of NADPH oxidase. The thrombin-induced oxidation of proteins and loss of hippocampal CA1 neurons were partially inhibited by an NADPH oxidase inhibitor and by an antioxidant. To our knowledge, the present study is the first to demonstrate that thrombin-induced neurotoxicity in the hippocampusin vivois caused by microglial NADPH oxidase-mediated oxidative stress. This suggests that thrombin inhibition or enhancing antioxidants may be beneficial for the treatment of neurodegenerative diseases, such as Alzheimer's disease, that are associated with microglial-derived oxidative damage.Keywords
This publication has 66 references indexed in Scilit:
- Activation of NADPH oxidase and extracellular superoxide production in seizure‐induced hippocampal damageJournal of Neurochemistry, 2004
- Microglia Promote the Death of Developing Purkinje CellsNeuron, 2004
- Microglia expressing interleukin‐13 undergo cell death and contribute to neuronal survival in vivoGlia, 2004
- Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia?Stroke, 2003
- Effects of tumor necrosis factor‐alpha central administration on hippocampal damage in rat induced by amyloid beta‐peptide (25–35)Journal of Neuroscience Research, 2002
- Effects of Normobaric Hyperoxia in a Rat Model of Focal Cerebral Ischemia—ReperfusionJournal of Cerebral Blood Flow & Metabolism, 2002
- Participation of protease‐activated receptor‐1 in thrombin‐induced microglial activationJournal of Neurochemistry, 2002
- Activation of NADPH Oxidase in Alzheimer's Disease BrainsBiochemical and Biophysical Research Communications, 2000
- Diphenyleneiodonium, an NAD(P)H Oxidase Inhibitor, also Potently Inhibits Mitochondrial Reactive Oxygen Species ProductionBiochemical and Biophysical Research Communications, 1998
- Thrombin accumulation in brains of patients with Alzheimer's diseaseNeuroscience Letters, 1992